Upstate Active Clinical Trials

Study Title:

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate
the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

What is the purpose of the study?

This study is being conducted to test the effect of CC-220 on improving your SLE, and to see how well your body tolerates CC-220.

Upstate Institutional Review Board (IRB) Number:

1122481

Study/Protocol ID:

CC-220-SLE-002

Study Phase:

Phase II

Patient Age Group:

Adults

Principal Investigator:

Andras Perl, MD, PhD

Who can I contact for more information?

Name: Ryan Kelly
Phone: 315-464-4194
Email: kellyr@upstate.edu

Return to Previous Page || Search Again

Top